Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.28.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used